BRENTUXIMAB VEDOTIN AS CONSOLIDATION TREATMENT IN PATIENTS WITH STAGE I/II CLASSICAL HODGKIN'S LYMPHOMA AND A POSITIVE FDG‐PET AFTER 2 CYCLES OF ABVD: A LYSA PHASE 2 STUDY.

Authors :: Gastinne, T.
Bouabdallah, K.
Moatti, H.
Tessoulin, B.
Shiano del colella, J. M.
Lamy, T.
Casasnovas, O.
Borel, C.
Stamatoullas, A.
Gac, A. C.
Chaoui, D.
Feugier, P.
Delmer, A.
Bonnet, C.
Fornecker, Luc‐M.
Lazarovici, J.
Le Bras, F.
Ghesquieres, H.
Meignan, M.
Traverse Glehen, A.
Source :: Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
Publication Year :: 2021

Full Text Access

Tools